For patients with cancer, tumors, and other serious or complex conditions, Japan is widely recognized as one of the world's leading medical destinations. Japan is at the global forefront in fields such as gastrointestinal cancer surgery, proton and heavy-ion radiotherapy, and immune cell therapy, with several of the world's best 5-year survival rates for specific cancers.
MIZUHO PHARMA specializes in connecting international patients with authoritative specialty hospitals in Japan — providing one-stop support from medical record review and specialist matching through to being accompanied throughout your visit, so patients can navigate an unfamiliar medical system with confidence and ease.
Japan's ranking worldwide for gastric cancer 5-year survival rate
Japanese Nobel laureates in Medicine
Cancer types that can be screened for in Japan
Japan has more proton and heavy-ion therapy facilities than any other country, allowing precise targeting of tumors while minimizing damage to surrounding healthy tissue, with significantly fewer side effects than conventional radiotherapy.
Japan is the only country in the world where BNCT is formally covered by national health insurance and used in commercial clinical practice. A boron-containing drug is injected into the body, where it selectively accumulates in cancer cells; a neutron beam then triggers a nuclear fission reaction that precisely destroys the cancer cells at the cellular level, with minimal damage to surrounding healthy tissue. It's particularly well suited to hard-to-treat tumors such as recurrent head and neck cancer or malignant glioma that respond poorly to conventional radiotherapy or cannot be surgically removed, and typically requires only one or two treatment sessions.
Japan's immunotherapy research is at the global forefront, with PD-1/PD-L1 inhibitors, CAR-T cell therapy, and other innovative immunotherapies among the first in the world to reach clinical use in Japan.
Japan's minimally invasive gastrointestinal cancer surgery techniques are highly refined; leading hospitals such as the Cancer Institute Hospital and the National Cancer Center report surgery-related mortality rates well below the international average.
Japan's leading hospitals widely practice multidisciplinary team case conferences, with specialists from surgery, internal medicine, radiology, and other departments jointly developing the optimal, individualized treatment plan.
Patients in the following situations are especially good candidates for pursuing medical resources in Japan
Patients with lung, gastric, liver, colorectal, breast, cervical, and other cancers — especially those in early or mid stages needing surgery, chemo/radiotherapy, or immunotherapy — can benefit significantly from Japan's treatment technology and 5-year survival rates.
Patients who have seen poor results, recurring symptoms, or no effective treatment plan after visiting multiple hospitals at home can gain an independent assessment and fresh treatment perspective from Japanese specialists.
Patients hoping to access proton and heavy-ion therapy, PD-1 immunotherapy, minimally invasive endoscopic resection, or other advanced treatments that aren't widely available or have long wait times at home.
Patients with a complex condition that couldn't be diagnosed, or for which no effective treatment plan was found, at home — Japan's multidisciplinary case-conference approach can offer a more thorough and precise diagnostic direction.
Japan's approval process for new cancer drugs moves relatively quickly, and some targeted and immunotherapy drugs not yet available at home have already been approved for clinical use in Japan, giving patients more treatment options.
Patients facing a major decision about whether to undergo surgery, or which surgical approach to take, can benefit from getting an authoritative opinion in Japan to help make a more informed medical decision.
From your first consultation through follow-up care after returning home, we provide professional support every step of the way
Our professional medical translation team translates and formats your medical records to the standards Japanese hospitals expect, ensuring your doctors in Japan accurately understand your condition.
We precisely match you with the most suitable specialty hospital and physician in Japan based on your specific condition, and help arrange your appointment to shorten the wait.
We help prepare the documents needed for your medical visa and guide you through the application process, ensuring you obtain your visa smoothly.
We help plan your trip to Japan, including flight recommendations, accommodation suggestions, and transportation to and from the hospital — so you can focus on your treatment, not logistics.
A professional medical interpreter accompanies you throughout, ensuring accurate communication between you and your Japanese doctors so no important medical information is lost.
We help translate your Japanese medical reports, track your ongoing progress, and provide the medical information support and follow-up consultation you need after returning home.
From your first consultation to your follow-up visit after returning home, the process typically takes 4 to 8 weeks
Contact MIZUHO PHARMA by email to share the patient's basic condition. Our medical advisor conducts a free initial assessment to determine whether treatment in Japan is a good fit.
Timeframe: 1–2 business daysThe patient provides complete medical records, including imaging reports, pathology reports, and test results. MIZUHO PHARMA arranges for a professional medical translation team to translate the materials into Japanese.
Timeframe: 3–5 business daysThe translated records are submitted to the matched Japanese hospital, where a specialist provides an initial assessment, confirms whether the case can be accepted, offers a general treatment direction, and provides a cost estimate.
Timeframe: 5–10 business daysOnce the patient and family confirm their intent to proceed, MIZUHO PHARMA formally books the outpatient or inpatient date at the Japanese hospital and assists with the medical visa and travel arrangements.
Timeframe: 1–2 weeksThe patient travels to Japan, accompanied throughout by MIZUHO PHARMA's professional interpreter. This period includes consultations, tests, developing a personalized treatment plan, and receiving treatment, with accurate communication ensured at every step.
Timeframe: depends on the treatment planOnce home, MIZUHO PHARMA helps translate the discharge report and treatment records from Japan, continues to track the patient's recovery, and helps arrange follow-up visits or remote communication with the Japanese doctor.
Ongoing support providedCosts vary considerably depending on your condition, treatment type, and choice of hospital. As a general guide, an initial visit in Japan (consultation, tests, and developing a treatment plan) typically costs approximately $7,000–$21,000 USD; if surgery or chemo/radiotherapy is performed in Japan, costs are typically $28,000 USD or more. (Figures are rounded USD estimates converted from the original RMB pricing.) MIZUHO PHARMA provides a detailed cost estimate before confirming your treatment plan, helping you prepare fully in advance.
Japan has clear strengths in the following areas: gastrointestinal cancers such as gastric, esophageal, and colorectal cancer; common cancers such as lung, liver, and breast cancer; solid tumors requiring proton or heavy-ion therapy; and various cancers requiring PD-1/PD-L1 immunotherapy. Japan also has strong capabilities in complex cardiovascular, cerebrovascular, and neurosurgical procedures.
Treatment in Japan typically requires a "Medical Stay" visa (the medical-purpose category of the short-term stay visa) or a "Designated Activities" visa (for longer treatment periods). Applications require documents such as a letter of acceptance and diagnostic certificate from the Japanese hospital. MIZUHO PHARMA helps prepare your visa materials and provides interview guidance to ensure a smooth application.
Not at all. MIZUHO PHARMA provides professional medical interpretation and accompanies you throughout every appointment. Our interpreters have a medical background and can accurately convey your doctor's diagnosis and treatment recommendations, ensuring smooth communication between you and your Japanese doctors.
From your first consultation to receiving treatment in Japan, the process typically takes 4 to 8 weeks, including medical record translation (about 1 week), assessment and booking with the Japanese hospital (2 to 4 weeks), and visa processing (about 2 weeks). For urgent cases, MIZUHO PHARMA prioritizes coordination to shorten the wait as much as possible.
Yes. We recommend 1 to 2 accompanying family members, who can also apply for a caregiver visa. MIZUHO PHARMA helps arrange family members' visa applications and travel plans as well, so patients have the full support of their family during treatment.
Wherever you are in your journey, MIZUHO PHARMA's medical advisors can provide a professional initial assessment and guidance. Your first consultation is completely free.
